If you have designed anything, you have likely failed a test at some point. We have so many requirements to meet, and there are so many analysis assumptions involved. For new products and new ...

Blood-based circulating tumor DNA (ctDNA) testing has proven to be insufficient for detecting KRAS mutations in patients with low-grade serous ovarian cancer (LGSOC), according to a study. The ...

The results are a blow to a fast-growing field that aims to catch cancer earlier, when treatment may be easier and more effective. HealthDay News — A blood test designed to find cancer early did not ...

BOSTON--(BUSINESS WIRE)--Delve Bio, a UCSF spin-out and pioneer in metagenomic next-generation sequencing (mNGS) for infectious diseases, announced data underscoring the clinical impact of mNGS using ...

Why did the test fail: the product, the test, the data or the environment? An evidence-based triage rulebook with rules and 21 labelled cases.

Animal models of human disease have extremely mixed results, and all too often they do not work well and accomplish their goals of helping humans. 1 One such procedure, the forced swim test, is a ...